This excerpt taken from the GILD 10-Q filed May 6, 2005.
JT Updates). Each JT Update will revise and/or describe, as necessary or appropriate, among other things: (A) scope, tasks and estimated timelines for JTs conduct of regulatory and clinical studies for Product, including without limitation clinical trial protocols, estimated enrollment numbers, filing submission dates for such activities; (B) any other
significant matters relating to clinical and pre-clinical development, regulatory filings and manufacturing; (C) a comparison of the then-current Development status for Product against the JT Development Plan or any previous JT Update; (D) a summary of material differences between such JT Update and the initial JT Development Plan or previous JT Update; and (E) other agenda items. Such JT Update shall be submitted to the Joint Committee for review and comment in advance of the meeting of the Joint Committee at which it is to be discussed.